Biological studies on in vitro cell cultures are of fundamental importance to investigate cells response to external stimuli, such as new drugs for treatment of specific pathologies, or to study communication between electrogenic cells. Although three-dimensional (3D) nanostructures brought tremendous improvements on biosensors used for various biological in vitro studies, including drug delivery and electrical recording, there is still a lack of multifunctional capabilities that could help gaining deeper insights in several bio-related research fields. In this work, the electrical recording of large cell ensembles and the intracellular delivery of few selected cells are combined on the same device by integrating microfluidics channels on the bottom of a multi-electrode array decorated with 3D hollow nanostructures. The novel platform allows to record intracellular-like action potentials from large ensembles of cardiomyocytes derived from human Induced Pluripotent Stem Cells (hiPSC) and from the HL-1 line, while different molecules are selectively delivered into single/few targeted cells. The proposed approach shows high potential for enabling new comprehensive studies that can relate drug effects to network level cell communication processes.
Introduction
Intracellular delivery is a fundamental method to study diseases and to investigate biological processes that affect cell functioning and communication with the extracellular environment. Plasmids, nanoparticles, fluorescent dyes or any bio-molecule need to be injected into cells to study their effects on physiology 1 . However, their introduction in the intracellular compartment is often challenging due to the cellular membrane that acts as barrier. Cytosolic delivery relies on established methods to transfer reagents across the cell membrane, such as viral vectors 2 for single-cell gene transfection and endocytosis of specific carriers (lipofectamine, cationic polymers). However, these methods are often hampered by lack of specificity, low efficiency, high expenses and even toxicity to the cell itself, as well as for specifically inhibiting signal transduction pathways that often involve small peptide inhibitors of protein kinases that are not cell-permeant. These drawbacks have led to the development of more direct approaches to physically breach the cell membrane, among which micropipetting and electroporation are the most common 3, 4 . Furthermore, recent advances in nanofabrication techniques, together with a deepened understanding of the cell-substrate interaction 5, 6 , have enabled the realization of nanostructured platforms for improved intracellular delivery 7, 8 , providing selectivity, lower invasiveness and better localization of the delivery process. As we have recently shown, using high aspect ratio 3D hollow gold nanoelectrodes in combination with electroporation or optoporation, it is possible to open transient nanopores into the cell membrane with controlled spatial localization and without compromising the cell/nanoelectrode coupling, allowing for intracellular delivery controlled in space and time 9, 10 .
For the investigation of neurons and cardiomyocytes, which are among the most important cells in regard to drug development and cell biology, the monitoring of their electrical activity is fundamental for their proper characterization, especially in large cultures where collective behavior can influence the functioning of single cells 11 . Consequently, biological experiments in which molecules or drugs are delivered to these cells should be implemented also in their recording capabilities to gain comprehensive insights into the delivery effects. However, the fabrication complexity of nano-fluidic nanostructures prevented so far the realization of devices that could integrate intracellular delivery and electrical recording on the same platform. In fact, with biosensors for electrical recording of electrogenic cell cultures, such as multi-electrode arrays (MEAs) and CMOS-MEAs [12] [13] [14] , the common drug delivery methods are mostly performed on entire cellular networks, which are globally affected by the treatment under investigation. Deeper and more crucial understandings could be gained by investigating the firing activity of large cell populations in which only single or few identified cells have been addressed by intracellular delivery. For example, pathologies may be induced to only few cells in order to study the reaction of the whole culture, simulating thus the early stage development of several diseases, or alternatively, drugs may be administered on partial regions of a cell culture to evaluate the electrical response in the case of inhomogeneous drug distribution 15 . In the case of cardiomyocytes, the signal propagation over the culture could reveal unexpected behaviors of the syncytia between delivered and unaffected cells. In recent years, several approaches have been presented to implement microfluidics on MEA through PDMS (Polydimethylsiloxane) or polymer channels placed onto the surface of the arrays [16] [17] [18] . These strategies provided ways, for example, to configure different culture conformations by confining cell growth into compartments. However, they do not reach the spatial resolution required to address single cells for drug delivery nor do they provide a nanoscale interface for intracellular access.
In an attempt to fill this technological gap, here we present a novel multifunctional MEA biosensor that combines network level electrical recording with single cell intracellular delivery, realizing a complete and ready-to-use platform for extra-/intracellular recordings of electrogenic cells (cardiomyocytes) and simultaneous molecule delivery in a non-invasive and selective way (figure 1a). The proposed system consists of a MEA design fabricated on a very thin silicon nitride membrane and decorated with three-dimensional (3D) hollow nanostructures. In this configuration, the MEA layout allows recording of large ensembles of cells and addressing of few to single cells with high spatio-temporal control, whereas the hollow nanostructures enable controlled delivery of reagents in specific locations of the cell culture.
Results and discussion
The biosensor concept
The novel platform is built on the well-established concept of the passive MEA device, which consists of a matrix of planar gold electrodes and represents the gold standard for the electrical characterization of large cell networks.
In our approach, the typical elements of the MEA structure (electrodes, feed lines, passivation) are fabricated on a thin silicon nitride layer (500 nm) deposited on a silicon wafer (see a representative sketch in figure 1a and the MEA photograph in figure 2c ). On the backside of the MEA we selectively remove the silicon beneath the Si3N4 layer, forming two or more thin nitride membranes (see figure 2d, f and figure S3 ) that run underneath the gold electrodes and act as microfluidic channels (micro-channels). Each MEA electrode is decorated with 3D gold nanotubes that are through-hole (see figure 2e, g), thus connecting the two sides of the thin nitride membrane. In essence, exploiting the favourable geometric characteristics of 3D hollow metallic nanopillars, we can take advantage of electroporation to get direct access to the cell interior with high spatial localization and perform multiple functionalities at the same time. On the one hand, they act as nano-fluidic channels for the flow of molecules or drugs from the underlying channels, providing a way to deliver them locally only to the cells lying on the nanotubes. On the other hand, the gold nanotubes are connected to the planar MEA electrode and offer electrical recording with major improvements over signal quality and spatio-temporal resolution for the recording of large population of cells 19, 20 , increasing the cell-electrode seal resistance and thus reducing parasitic signal losses.
For our experiments, we used a MEA array of 24 electrodes placed in a 4×6 matrix and with an inter-electrode pitch of 400 µm, resulting in an active area of 2×1.2 mm 
Electrophysiological recording of cardiomyocyte spontaneous beating and electroporation
The microfluidic-MEAs (MF-MEAs) were packaged using a custom-designed PCB board (figure 2a In supporting information we report additional electrical measurements performed on hiPSC cardiomyocytes 
Intracellular delivery
In order to test the effectiveness of our multifunctional platform, we performed selective delivery of molecules through the 3D nanoelectrodes during the recording sessions. The hollow nanoelectrode design enables to address only few selected cells, without affecting the electrical activity of the whole network. As a first proof-of-concept of our technology, calcein-AM, a membrane permeant molecule producing a green fluorescence at λ=515 nm, was delivered at a concentration of 200 M in a Phosphate Buffer Solution (PBS) 1X to the cells (electroporated or not) interfacing the 3D nanoelectrodes on the Si3N4 membrane. The desired solution was previously incubated at 37 °C, and was then injected with our pumping system into the two isolated microchannels, allowing the fluorophores to diffuse through the nanoelectrode just in small portions of the biosensor surface. Figure 3a shows the green fluorescence image acquired with an optical microscope (air objective 5×) while the whole cell culture was live and electrically active. The fluorescence image were taken 1 hour after the addition of calcein-AM in the microfluidic channels below the MEA. This time was needed to allow the calcein-AM to diffuse into the 3D hollow nanoelectrodes and to access the cellular membrane. Before imaging, the calcein-AM solution was then substituted by PBS in order to rinse both the tubing and the microchannels, removing calcein-AM residuals. As it can be seen, calcein-AM is selectively delivered only to the cells that are tightly sealed on top of the nanostructured electrodes.
The delivery selectivity reaches almost 100% thanks to the tight cell adhesion on the hollow nanopillars, which prevents the diffusion of the dye molecule into the rest of the cell culture.
In other experiments, we injected into the microfluidic channels a saline solution with Propidium Iodide (PrhD-1), a non-permeant molecule which binds nucleic acids and emits a bright red fluorescence at λ=635 nm, with a concentration of 1 mM in PBS 1X. Electroporation pulses were applied through the 3D nanoelectrodes of the MEA electrodes interfacing the microfluidic channels in order to open transient pores in the cellular membrane and to deliver the PrhD-1 inside the cells. As it can be seen in figure 3b and 3c, PrhD-1 is delivered only to the cardiomyocytes laying on the electrodes and hence subjected to electroporation, thus providing a clear evidence of the high selectivity and spatial control achieved by our multifunctional platform. We also investigated the possibility to deliver non-permeant and permeant molecules through the same microfluidic channels. Figure 3d, e, f shows bright-field and fluorescence images of four MEA electrodes (A, B, C and D) after we delivered both calcein-AM and PrhD-1 and applied selective electroporation only to electrodes B and D. We observe the selective delivery of calcein-AM on the cells laying on the four electrodes (figure 3e), whereas we note that PrhD-1 is delivered only to the electroporated cells laying on the electrodes B and D (figure 3f). The fluorescence images were acquired simultaneously with the electrical recording of the same cells, which indeed showed polarity inversion of the recorded signals due to the intracellular action potential contribution (insets in figure 3e, f) . The same experiments were performed on different sets of electrodes, finding good results in terms of reproducibility and intracellular selectivity (see figure S6 ). The cells were fixated after recording and delivery in order to acquire high resolution images of fluorescence emission with a confocal microscope. Figure 3g shows the detail of one electrode on which we have delivered calcein-AM and PrhD-1 and applied electroporation. We can observe the red staining of the nuclei due to PrhD-1 and the surrounding green fluorescence due to the calcein-AM staining the cell cytoskeleton.
Further, we studied the effects of culturing the cells over a heterogeneous sample consisting of areas on bulky silicon and other regions on thin nitride membrane with PBS underneath, so as to evaluate possible divergences in cell proliferation. HL-1 cells were cultured on the microfluidic MEAs and stained with DAPI, a blue staining of the nuclei, after 4 DIV. In this case, the staining with DAPI was performed on the complete culture from the glass culture well, rather than selectively from the microfluidic channels. The images reveal a homogeneous cell growth over the whole MEA surface, with no distinction between the free-standing nitride membranes and the bulk silicon part (figure 3h). This ensures that the particular employed device configuration does not influence the cell culture growth and development. Moreover, the cell density estimate reported in figure S7 yields similar values on different areas (bulk silicon or nitride membranes) of the same device. Figure 3i shows a detail of four electrodes after delivery of calcein-AM through the 3D nanoelectrodes and staining with DAPI from the cell culture well. 
Experimental Fabrication of nitride membrane and independent microfluidic channels
In order to obtain a compact and flow-through design, nanostructured MEAs were realized on thin silicon nitride (Si3N4) membranes. Membranes and micro-channels were fabricated on a 525 µm thick p-doped (100) Si wafer with 500 nm of LPCVD super low stress Si3N4 on both sides (see figure S1 for fabrication protocol). A 400 nm thick mask layer of Cr was sputter coated on one of the two wafer sides and a thin layer (≈ 2 µm thick) of a common photoresist (MICROPOSIT S1813) was spin-coated on top. Conventional optical UV lithography (SÜSS MicroTec Mask Aligner) was employed to expose the desired areas (see figure S1) . 
Microfluidic-MEA
MEAs decorated with 3D nano-electrodes were fabricated using the technologies developed in other works (Dipalo M. et al., Nanoscale 2015, De Angelis F. et al., Nano Letters 2013). Briefly, a thin layer (≈ 2 µm thick) of S1813 was spin-coated on the Si3N4 membrane (see figure S2 for fabrication protocol). After UV exposure and 60 seconds development in MF-319, 24 Ti/Au electrodes, conductive tracks and contact pads were fabricated through electron beam evaporation in a high vacuum chamber (base pressure 10 -7 mbar) with a 0.3 Å/s deposition rate. The unexposed resist and the metal on top of it were removed through a conventional lift-off process in hot Remover PG (MicroChem). The substrate was then rinsed out in isopropanol (IPA) and dried with nitrogen. O2 plasma ashing at 100 W for 5 minutes was used to remove residual S1813 resist and other organic residues. 24 electrode contacts of varying dimensions (from 100 to 900 µm In the following, we will only consider the case of two isolated membranes with 8 nanostructured electrodes each. The remaining 8 planar electrodes will be used as controls.
MEA packaging
The complete MEA with nanostructured electrodes was then mounted on a PCB (printed-circuit-board) and As a last step, using biopsy punches holes were drilled through the PDMS piece (in correspondence with the micro-channels underneath) and tubing was added to provide external connections with our pumping system (see figure 2b ).
Pumping system
A commercial pressure-driven microfluidic flow control system (MFCS-EZ, FLUIGENT) was employed to selectively deliver different solutions in the microfluidic chambers underneath the nitride membranes. By connecting the system pressure outputs to airtight reservoirs, containing the desired reagents, we were able to precisely control the liquid flow into the microfluidic device. The flow-rate was adjusted to 100 μL/min to ensure flow stability and smoothness.
Culture of HL-1 cardiomyocytes
The MF-MEAs have been sterilized with 20 minutes-UV exposure in laminar flow hood and incubated overnight (o.n.) with Claycomb culture medium in order to saturate the PDMS porous matrix of the culture well.
Furthermore, the micro-channels and tubing at the bottom of the device have been manually filled with Claycomb using a sterile syringe. The day after, the medium has been completely removed from the culture well and the substrates have been treated with poly-L-lysine 0,01% w/v (Sigma-Aldrich) for five minutes, washed extensively with water and let dry in sterile condition. Subsequently, HL1 cells have been seeded at the density of 35000/cm 2 and grown with Claycomb, supplemented with 10% fetal bovine serum, 100 µM norepinephrine, 300 µM ascorbic acid, 2 mM L-glutamine, penicillin and streptomycin (Sigma-Aldrich). The culture medium has been changed daily. When 100% confluence was reached, the electrical activity of cells has been recorded.
Human induced Pluripotent Stem Cells-derived cardiomyocytes
HiPSCs ( then incubated for 30 minutes at 37°C in a humidified environment. As a following step, the solution was totally removed and cells were rapidly plated without the coating was allowed to dry. HiPSCs-derived cardiomyocytes have been plated at the density of 70000/ cm 2 and grown with Cor.4U complete medium.
Cell fixation
Samples were fixed with PFA 4% in PBS. After a 30 minutes incubation at room temperature, samples have been extensively washed with PBS and treated with Triton 0.1% in PBS and stained with DAPI (Invitrogen) in order to mark the nuclear compartment of cells.
Fluorescence imaging and confocal microscopy
Confocal imaging of HL-1 cardiomyocytes was performed with a Leica TCS SP5 AOBS Tandem DM6000 upright microscope equipped with a 25× objective (Leica IRAPO, NA = 0.95). Data were subsequently analyzed by LASX V2.0 software (Leica Microsystems). Fluorescence imaging during electrical recording was performed with a Nikon FN-1 microscope using 5× and 20× air objectives and a 60× water-immersion objective.
Conclusion
In this work, we presented a novel multifunctional biosensing platform with high level integration of microfluidics and recording capabilities. The approach combines various bio-nanotechnologies to perform selective intracellular delivery of molecules, extracellular action potential recording and intracellular recording by means of electroporation. We successfully performed intracellular recording of human iPSC derived cardiomyocytes and intracellular delivery of two different molecules in few selected cells, while the electrical activity of the whole cultures was monitored.
The peculiar properties of the 3D gold hollow nanostructures and of the multiple microfluidic channels will allow to inject molecules into selected cells and to measure the consequent response of the whole cell network. Moreover, different molecules may be injected in various and specific parts of the cell culture through independent microfluidic channels, so that the electrical response of the cell culture can be observed also in the presence of multiple drugs or molecules. The platform may provide new methodologies to study early stage pathologies and to evaluate toxicity of drugs, molecules and nanoparticles. In perspective, the same configuration may be used in the future also for performing intracellular sampling as already suggested by Y. Cao et al. 27 , combining intracellular sampling and electrical recording of the same cells in a large network.
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Supporting Information
Selective intracellular delivery and intracellular recordings combined on MEA biosensors Fluorescence image, acquired on the other membrane region of the same device, of cardiomyocytes cultured on MF-MEA and stained with DAPI after 4 DIV. The red-bordered area delimits the nitride membrane. The scale bar is 300 m. c) Box plot featuring the cell density distribution calculated for different areas (bulk silicon or nitride membranes) on the same device.
